YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models - Concepedia

Concepedia

Publication | Open Access

YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models

DOI Full Paper Access

33

Citations

33

References

2014

Year

Yong Xia, Xuejiao Song, Deliang Li, Tinghong Ye, Youzhi Xu, Hongjun Lin, Nana Meng, Guo‐Bo Li, Senyi Deng, Shuang Zhang,

Scientific Reports

References

	Year	Citations

Page 1